Skip to content
S.C. Monoclonal Antibodies episode artwork

Mar 8, 2019 14 min

S.C. Monoclonal Antibodies

from OncoPharm Hosted by John Bossaer

Coming to a P & T committee meeting near you....it's subcutaneous (S.C.) monoclonal antibodies. We discuss the two currently FDA-approved formulations: rituximab + hyaluronidase and trastuzumab + hyaluronidase.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

S.C. Monoclonal Antibodies

0:00 14:01

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OncoPharm?

This episode is 14 minutes long.

When was this OncoPharm episode published?

This episode was published on March 8, 2019.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.